News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
100,262 Results
Type
Article (3032)
Company Profile (13)
Press Release (97217)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (36442)
Career Advice (65)
Deals (6130)
Drug Delivery (13)
Drug Development (11909)
Employer Resources (13)
FDA (1955)
Job Trends (2367)
News (54102)
Policy (3035)
Tag
Academia (231)
Accelerated approval (6)
Allergies (36)
Alliances (3643)
ALS (47)
Alzheimer's disease (258)
Antibody-drug conjugate (ADC) (94)
Approvals (2118)
Artificial intelligence (166)
Autoimmune disease (44)
Automation (13)
Bankruptcy (55)
Best Places to Work (2395)
BIOSECURE Act (3)
Biosimilars (56)
Biotechnology (11)
Bladder cancer (88)
Brain cancer (12)
Breast cancer (262)
Cancer (1695)
Cardiovascular disease (139)
Career advice (63)
Career pathing (3)
CAR-T (81)
CDC (4)
Cell therapy (203)
Cervical cancer (18)
Clinical research (12248)
Collaboration (545)
Company closure (1)
Compensation (626)
Complete response letters (5)
COVID-19 (312)
CRISPR (27)
C-suite (218)
Cystic fibrosis (40)
Data (2187)
Depression (23)
Diabetes (118)
Diagnostics (1065)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (67)
Drug pricing (16)
Drug shortages (3)
Duchenne muscular dystrophy (59)
Earnings (32734)
Editorial (4)
Employer branding (1)
Employer resources (10)
Events (13052)
Executive appointments (369)
FDA (3061)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (9)
Funding (484)
Gene editing (57)
Generative AI (7)
Gene therapy (154)
GLP-1 (216)
Government (392)
Grass and pollen (3)
Guidances (310)
Healthcare (2919)
HIV (26)
Huntington's disease (10)
IgA nephropathy (39)
Immunology and inflammation (38)
Immuno-oncology (9)
Indications (30)
Infectious disease (397)
Inflammatory bowel disease (37)
Inflation Reduction Act (1)
Influenza (29)
Intellectual property (49)
Interviews (7)
IPO (4716)
IRA (3)
Job creations (253)
Job search strategy (53)
Kidney cancer (6)
Labor market (9)
Layoffs (41)
Leadership (2)
Legal (526)
Liver cancer (25)
Longevity (2)
Lung cancer (263)
Lymphoma (145)
Machine learning (11)
Management (5)
Manufacturing (172)
MASH (51)
Medical device (2377)
Medtech (2389)
Mergers & acquisitions (1760)
Metabolic disorders (310)
Multiple sclerosis (44)
NASH (5)
Neurodegenerative disease (79)
Neuropsychiatric disorders (20)
Neuroscience (570)
NextGen: Class of 2025 (743)
Non-profit (550)
Now hiring (2)
Obesity (149)
Opinion (10)
Ovarian cancer (55)
Pain (40)
Pancreatic cancer (50)
Parkinson's disease (68)
Patents (87)
Patient recruitment (131)
Peanut (17)
People (4059)
Pharmaceutical (6)
Pharmacy benefit managers (4)
Phase I (3225)
Phase II (5059)
Phase III (4835)
Pipeline (2031)
Policy (16)
Postmarket research (438)
Preclinical (974)
Press Release (2)
Prostate cancer (90)
Psychedelics (8)
Radiopharmaceuticals (38)
Rare diseases (180)
Real estate (362)
Recruiting (2)
Regulatory (3028)
Reports (16)
Research institute (221)
Resumes & cover letters (4)
Rett syndrome (16)
RSV (36)
Schizophrenia (39)
Series A (64)
Series B (62)
Sickle cell disease (25)
Special edition (3)
Spinal muscular atrophy (13)
Sponsored (3)
Startups (213)
Stomach cancer (1)
Supply chain (34)
Tariffs (3)
The Weekly (4)
Vaccines (159)
Venture capital (16)
Weight loss (79)
Women's health (24)
Worklife (1)
Date
Today (49)
Last 7 days (210)
Last 30 days (854)
Last 365 days (12104)
2025 (11876)
2024 (8882)
2023 (7228)
2022 (8670)
2021 (8987)
2020 (8239)
2019 (6997)
2018 (5162)
2017 (4301)
2016 (3450)
2015 (4300)
2014 (2820)
2013 (1766)
2012 (2103)
2011 (2551)
2010 (2402)
Location
Africa (67)
Alabama (14)
Arizona (35)
Arkansas (4)
Asia (5370)
Australia (781)
California (4401)
Canada (949)
China (274)
Colorado (168)
Connecticut (198)
Delaware (193)
Europe (14175)
Florida (401)
Georgia (111)
Hawaii (2)
Idaho (8)
Illinois (305)
India (12)
Indiana (125)
Iowa (7)
Japan (192)
Kansas (14)
Kentucky (13)
Louisiana (10)
Maine (13)
Maryland (380)
Massachusetts (3245)
Michigan (111)
Minnesota (208)
Mississippi (1)
Missouri (45)
Montana (4)
Nebraska (3)
Nevada (48)
New Hampshire (24)
New Jersey (1119)
New Mexico (6)
New York (954)
North Carolina (404)
North Dakota (2)
Northern California (2098)
Ohio (101)
Oklahoma (6)
Oregon (6)
Pennsylvania (592)
Puerto Rico (1)
Rhode Island (13)
South America (109)
South Carolina (5)
Southern California (1696)
Tennessee (69)
Texas (624)
United States (14123)
Utah (82)
Vermont (1)
Virginia (98)
Washington D.C. (18)
Washington State (311)
West Virginia (3)
Wisconsin (76)
100,262 Results for "36".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
November 24, 2025
·
10 min read
Press Releases
DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing
December 11, 2025
·
3 min read
Press Releases
Next-Generation Cancer Diagnostics Market Size Worth USD 38.36 Billion by 2034
November 18, 2025
·
1 min read
Cardiovascular disease
Amgen’s Repatha Cuts Risk of First Heart Attack by 36% in Phase III Trial
The cholesterol-lowering drug is part of a suite of medicines that also includes MariTide and that Amgen Chief Medical Officer Paul Burton hopes will make the company the “undisputed leader in the management of cardiometabolic risk for patients” by 2030.
November 10, 2025
·
4 min read
·
Heather McKenzie
Press Releases
Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoint Antibody in Solid Tumors
December 16, 2025
·
4 min read
Press Releases
Pilatus Biosciences Announces Issuance of Foundational Global Patent Covering Novel CD36-Targeted Immunotherapy
October 15, 2025
·
3 min read
Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development
October 30, 2025
·
5 min read
Press Releases
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025
December 16, 2025
·
2 min read
Press Releases
Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
October 29, 2025
·
7 min read
Press Releases
EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU
October 21, 2025
·
5 min read
1 of 10,027
Next
